S Biomedics Co (XKRX:304360) Ending Cash Position : ₩1,629 Mil (As of Mar. 2024)

View and export this data going back to 2023. Start your Free Trial

What is S Biomedics Co Ending Cash Position?

S Biomedics Co's Ending Cash Position for the quarter that ended in Mar. 2024 was ₩1,629 Mil.

S Biomedics Co's quarterly Ending Cash Position declined from Sep. 2023 (₩4,428 Mil) to Dec. 2023 (₩1,410 Mil) but then increased from Dec. 2023 (₩1,410 Mil) to Mar. 2024 (₩1,629 Mil).

S Biomedics Co's annual Ending Cash Position declined from Dec. 2020 (₩9,188 Mil) to Dec. 2021 (₩6,131 Mil) and declined from Dec. 2021 (₩6,131 Mil) to Dec. 2022 (₩4,066 Mil).

S Biomedics Co Ending Cash Position Historical Data

The historical data trend for S Biomedics Co's Ending Cash Position can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

S Biomedics Co Ending Cash Position Chart

S Biomedics Co Annual Data

Trend

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Ending Cash Position

Get a 7-Day Free Trial

2,667.48

3,425.73

9,188.38

6,131.39

4,065.83

S Biomedics Co Quarterly Data
	Jun19	Sep19	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24
Ending Cash Position	Get a 7-Day Free Trial															1,987.07	3,269.47	4,427.96	1,410.06	1,629.41

S Biomedics Co Ending Cash Position Calculation

Ending Cash Position is the cash and cash equivalents balance at the end of the accounting period, as indicated on the Cash Flow statement. It is equal to the Beginning Cash Position plus the Net Change in Cash.

S Biomedics Co's Ending Cash Position for the fiscal year that ended in Dec. 2022 is calculated as

Ending Cash Position	=	Beginning Cash Position	+	Net Change in Cash
	=	6131.389	+	-2065.563
	=	4,066

S Biomedics Co's Ending Cash Position for the quarter that ended in Mar. 2024 is calculated as

Ending Cash Position	=	Beginning Cash Position	+	Net Change in Cash
	=	1410.057	+	219.352
	=	1,629

S Biomedics Co Ending Cash Position Related Terms

Thank you for viewing the detailed overview of S Biomedics Co's Ending Cash Position provided by GuruFocus.com. Please click on the following links to see related term pages.

S Biomedics Co (XKRX:304360) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » S Biomedics Co Ltd (XKRX:304360) » Definitions » Ending Cash Position

Comparable Companies

Traded in Other Exchanges

N/A

Address

Seongsui-ro 26-gil, 4th Floor, Wooil Venture Town Building 28, Seongdong-gu, FedEx building, Seoul, KOR, 04797

Website

https://www.sbiomedics.com

S Biomedics Co Ltd researches and develops cell therapies for regenerative biomedicine. It owns two platform technologies: Functionally Enhanced Cell Spheroid and Targeted Embryonic Stem Cell Differentiation for developing cell therapy products that overcome the limitations of existing cell therapy products.

S Biomedics Co (XKRX:304360) Headlines

No Headlines